Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus

Meng-Meng Shi1,2, Antoine Monsel3,4,5, Jean-Jacques Rouby3

  • 1Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in Microbiology
|October 23, 2019
PubMed
Abstract

Insights

Coagulase-negative staphylococci (CoNS) pneumonia is controversial. In mice, Staphylococcus haemolyticus caused lung infection that resolved over time, independent of biofilm formation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • The role of coagulase-negative staphylococci (CoNS) in causing pneumonia, particularly in mechanically ventilated patients, remains debated.
  • Staphylococcus haemolyticus is frequently found in respiratory secretions, but its pathogenic potential in the lungs is not well-established.

Purpose of the Study:

  • To investigate the capacity of Staphylococcus haemolyticus to infect lung parenchyma in a mouse model.
  • To determine the dose-dependent effects and resolution of Staphylococcus haemolyticus-induced lung infection.

Main Methods:

  • Immunocompetent mice were intratracheally inoculated with varying concentrations of live or inactivated Staphylococcus haemolyticus or phosphate-buffered saline (PBS).
  • Animals were analyzed at 12 and 36 hours post-inoculation, with assessments including bronchoalveolar lavage (BAL) analysis, lung histology, and quantitative bacteriology.
  • Biofilm-associated gene distribution was examined in the experimental strain and other clinical isolates.

Main Results:

  • High-dose (1.0 × 10^8 CFU) live Staphylococcus haemolyticus induced macroscopic and histological pneumonia with increased inflammatory markers in BAL fluid.
  • Lung injury and inflammation decreased by 36 hours, with the emergence of oropharyngeal flora in lung tissue, suggesting resolution.
  • Lower doses and inactivated bacteria also caused interstitial pneumonia and BAL inflammation, while biofilm formation was common and independent of the ica operon.

Conclusions:

  • Staphylococcus haemolyticus can cause a concentration-dependent lung infection in immunocompetent mice that resolves spontaneously.
  • Biofilm formation in Staphylococcus haemolyticus is a common phenotype, often independent of the icaA and icaD genes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
680
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
747
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.3K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
709